Trending News Today: Cigna-Express Scripts Merger Faces Antitrust Uncertainty

Last week, an agreement was announced in which Cigna would purchase Express Scripts for $67 billion. Although leaders of both companies said the merger would streamline patient care, it may face significant scrutiny from antitrust regulators who will determine whether the deal will be beneficial to consumers, according to Bloomberg. The key questions regulators will have to answer is how much more efficient could the merger make health care delivery and what savings will be passed on to patients, according to the article. The newly-proposed consolidation comes soon after talks of a merger between CVS Health and Aetna. 

A federal judge recently ordered Walgreen Co to face a proposed class action lawsuit that accuses the pharmacy chain of overcharging insured customers for generic drugs for more than a decade, The New York Times reported. The lawsuit alleges that Walgreen charges insured customers more than those in its direct-pay Prescription Savings Club. The judge said Walgreen misled insurers when seeking reimbursement and that insured customers should expect to pay the same as those paying without insurance, according to the Times.

The overdose death toll in West Virginia improved from 887 fatal overdoses in 2016 to 872 in 2017, according to The New York Times. The death toll of 52 per 100,000 residents in West Virginia was the highest in the United States in 2016. The slight progress is attributable to modifying response by identifying risk factors; however, public health experts are cautiously optimistic about the drop, according to the article.

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Most Popular

Related Articles

In this clip, Gordon Vanscoy, PharmD, MBA, CEO of PANTHERx Specialty Pharmacy, explains how orphan drugs are making an impact on patients in the era of precision medicine.
Gordon Vanscoy, PharmD, MBA, explains the challenges patients face when being treated with orphan drugs, and how pharmacists can help overcome these challenges.
Substituting brand name combination drugs for lower-cost generics could have reduced spending by $925 million in 2016.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$